![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 18, 15362-15368, May 4, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pharmacology and Cancer Biology, Duke
University Medical Center, Durham, North Carolina 27710
To examine signaling pathways underlying
transforming growth factor-
The Activity of Guanine Exchange Factor NET1 Is
Essential for Transforming Growth Factor-
-mediated Stress Fiber
Formation*
(TGF-
)-mediated changes in cell
morphology, we used a microarray system to identify downstream target
genes that may play a role in this process. Through this approach, we
found that the NET1 gene was induced upon TGF-
treatment in several cell types. NET1 is a guanine nucleotide exchange
factor for RhoA whose activity has been implicated in stress fiber
formation. In the Swiss 3T3 cell line, TGF-
induces NET1
expression, and this correlated with an increase in stress fiber
formation. Overexpression of the wild type NET1 gene
increases stress fiber formation, and overexpression of a dominant
negative NET1 mutant (L392E) prevented TGF-
dependent
increase in stress fiber formation. Furthermore, treatment of the cells
with a RhoA kinase inhibitor Y-27632 blocks TGF-
-induced stress
fiber formation. By using a stable cell line expressing dominant
negative Smad3, we found that the Smad signaling pathway is essential
for the induction of NET1, which in turn leads to the
increase of Rho activity. Taken together, those data suggest that
induction of NET1 is important for the increase of Rho
activity upon TGF-
treatment, which may represent the critical trigger for a variety of downstream events in different cells. Our
results support the presence of a novel signaling pathway by
which TGF-
may regulate the formation of stress fibers and reorganization of cytoskeletal structures.
*
This work was supported by National Institutes of Health
Grants DK45746 and CA75368 (to X. F. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology
and Cancer Biology, Box 3813, Duke University Medical Center, Durham,
NC 27710. Tel.: 919-681-4861; Fax: 919-681-7152; E-mail: wang@galactose.mc.duke.edu.
This article has been cited by other articles:
![]() |
Y. Q. Xiao, C. G. Freire-de-Lima, W. P. Schiemann, D. L. Bratton, R. W. Vandivier, and P. M. Henson Transcriptional and Translational Regulation of TGF-{beta} Production in Response to Apoptotic Cells J. Immunol., September 1, 2008; 181(5): 3575 - 3585. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Guo, A. Ramirez, D. S. Waddell, Z. Li, X. Liu, and X.-F. Wang Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling Genes & Dev., January 1, 2008; 22(1): 106 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhu, A. R. Krakowski, E. E. Dunham, L. Wang, A. Bandyopadhyay, R. Berdeaux, G. S. Martin, L. Sun, and K. Luo Dual Role of SnoN in Mammalian Tumorigenesis Mol. Cell. Biol., January 1, 2007; 27(1): 324 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Kim, J.-G. Kim, M.-Y. Moon, C.-Y. Jeon, H.-Y. Won, H.-J. Kim, Y.-J. Jeon, J.-Y. Seo, J.-I. Kim, J. Kim, et al. Transforming growth factor-beta1 regulates macrophage migration via RhoA Blood, September 15, 2006; 108(6): 1821 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lu, E. O. Harrington, H. Jackson, N. Morin, C. Shannon, and S. Rounds Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation J Appl Physiol, August 1, 2006; 101(2): 375 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, M. Crawford, R. M. Day, V. R. Briones, J. E. Leader, P. A. Jose, and R. J. Lechleider RhoA Modulates Smad Signaling during Transforming Growth Factor-beta-induced Smooth Muscle Differentiation J. Biol. Chem., January 20, 2006; 281(3): 1765 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levy and C. S. Hill Smad4 Dependency Defines Two Classes of Transforming Growth Factor {beta} (TGF-{beta}) Target Genes and Distinguishes TGF-{beta}-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses Mol. Cell. Biol., September 15, 2005; 25(18): 8108 - 8125. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Deaton, C. Su, T. G. Valencia, and S. R. Grant Transforming Growth Factor-{beta}1-induced Expression of Smooth Muscle Marker Genes Involves Activation of PKN and p38 MAPK J. Biol. Chem., September 2, 2005; 280(35): 31172 - 31181. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas and C.-H. Heldin Non-Smad TGF-{beta} signals J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maeda, K. R. Johnson, and M. J. Wheelock Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition J. Cell Sci., March 1, 2005; 118(5): 873 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Clements, F. L. Minnear, H. A. Singer, R. S. Keller, and P. A. Vincent RhoA and Rho-kinase dependent and independent signals mediate TGF-{beta}-induced pulmonary endothelial cytoskeletal reorganization and permeability Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L294 - L306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Masszi, C. Di Ciano, G. Sirokmany, W. T. Arthur, O. D. Rotstein, J. Wang, C. A. G. McCulloch, L. Rosivall, I. Mucsi, and A. Kapus Central role for Rho in TGF-beta 1-induced alpha -smooth muscle actin expression during epithelial-mesenchymal transition Am J Physiol Renal Physiol, May 1, 2003; 284(5): F911 - F924. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lamouille, C. Mallet, J.-J. Feige, and S. Bailly Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis Blood, December 15, 2002; 100(13): 4495 - 4501. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Arthur, S. M. Ellerbroek, C. J. Der, K. Burridge, and K. Wennerberg XPLN, a Guanine Nucleotide Exchange Factor for RhoA and RhoB, But Not RhoC J. Biol. Chem., November 1, 2002; 277(45): 42964 - 42972. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Bottinger and M. Bitzer TGF-{beta} Signaling in Renal Disease J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2600 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmidt and A. Hall The Rho Exchange Factor Net1 Is Regulated by Nuclear Sequestration J. Biol. Chem., April 19, 2002; 277(17): 14581 - 14588. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Edlund, M. Landstrom, C.-H. Heldin, and P. Aspenstrom Transforming Growth Factor-beta -induced Mobilization of Actin Cytoskeleton Requires Signaling by Small GTPases Cdc42 and RhoA Mol. Biol. Cell, March 1, 2002; 13(3): 902 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Goldberg, D. E. MacNaughton, R. T. Clements, F. L. Minnear, and P. A. Vincent p38 MAPK activation by TGF-beta 1 increases MLC phosphorylation and endothelial monolayer permeability Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L146 - L154. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Piek, W. J. Ju, J. Heyer, D. Escalante-Alcalde, C. L. Stewart, M. Weinstein, C. Deng, R. Kucherlapati, E. P. Bottinger, and A. B. Roberts Functional Characterization of Transforming Growth Factor beta Signaling in Smad2- and Smad3-deficient Fibroblasts J. Biol. Chem., June 1, 2001; 276(23): 19945 - 19953. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |